Nurix Therapeutics, Inc.

NASDAQ:NRIX

11.27 (USD) • At close May 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 75.916109.99799.044116.7949.81354.62742.30458.95833.57164.47447.55641.53378.7880.506147.44188.207126.381119.356265.527159.32956.4134.816-39.039
Short Term Investments 473.764499.586349.008326.349194.18233.281216.548222.219243.575244.667296.922255.746183.198215.214196.458197.814176.692161.79288.71614.17414.9372.90478.078
Cash and Short Term Investments 549.68609.583448.052443.139243.993287.908258.852281.177277.146309.141344.478297.279261.978295.72343.898386.021303.073281.148354.243173.50371.34737.7239.039
Net Receivables 0000002000008.2046.2045.2045.6793.98111.3463.85619.59000
Inventory 0000000-1-1.2-1.1-1.1-0.700000000000
Other Current Assets 14.0239.8047.9917.0786.9767.5957.0978.83711.1839.30810.3939.5110.3029.1949.3434.5813.7145.945.993.7115.3131.6340
Total Current Assets 563.703619.387456.043450.217250.969295.503267.949290.014288.329318.449354.871306.789280.484311.118358.445396.281310.768298.434364.089196.80476.6639.35439.039
Non-Current Assets:
Property, Plant & Equipment, Net 44.8145.89644.15247.39247.1747.9525.60828.43628.63429.50830.34930.92529.39425.3459.5698.3456.966.6726.5325.7893.9753.8710
Goodwill 00000000000000000000000
Intangible Assets 00000000000000000000000
Goodwill and Intangible Assets 000000000-3.301000-3.326000000000
Long Term Investments 00010.28111.1938.3229.88227.46348.44963.87969.12551.538123.685137.189121.48110.4477.19190.8940.8989.117.5840.5060
Tax Assets 000008.9410003.3010003.326000000000
Other Non-Current Assets 6.534.0613.4053.1413.3423.8234.7564.7114.7424.9234.9935.0584.157-0.2073.582.9151.7410.3470.3551.5740.570.317-39.039
Total Non-Current Assets 51.3449.95657.55760.81461.70569.03640.24660.6181.82598.31104.46787.521157.236165.653134.629121.785.89297.90947.78516.47312.1294.694-39.039
Total Assets 615.043669.343513.6511.031312.674364.539308.195350.624370.154416.759459.338394.31437.72476.771493.074517.981396.66396.343411.874213.27788.78944.0480
Liabilities & Equity:
Current Liabilities:
Account Payables 8.39711.4823.9182.8135.9186.4012.1874.5255.6295.0646.0536.1426.0146.653.8615.4054.3883.4123.6114.9032.1271.5980
Short Term Debt 6.6398.01413.10615.86814.6214.97810.72411.16611.11211.0610.99210.9410.867.694000000000
Tax Payables 1.3321.2370.9060.710.4270.030.0340.0160.0890.0850.0410.0260.0530.0750.03700.3250.0740000.0330
Deferred Revenue 30.59138.36447.99746.76946.07748.09832.03744.06338.30537.63336.34241.31943.18641.21235.2533.76132.75132.79930.29925.37209.6120
Other Current Liabilities 43.02936.75720.36914.61920.58117.45116.51112.4929.74316.81314.07214.2385.93610.62711.5327.67810.5088.2547.1024.16127.9064.8940
Total Current Liabilities 89.98895.85486.29680.77987.62386.95861.49372.26264.87870.65567.572.66566.04966.25850.6846.84447.97244.53941.01234.43630.03316.1370
Non-Current Liabilities:
Long Term Debt 020.28920.5941.7743.69246.255.2847.51610.21212.86815.4918.08620.65218.378000000000
Deferred Revenue Non-Current 026.20729.85838.67434.45745.02210.24314.68326.11835.97441.54845.86355.42859.02266.38172.12277.72360.68562.37471.387035.6930
Deferred Tax Liabilities Non-Current 000-38.67408.941-10.243-14.683-26.1183.301-41.548-45.863-55.4283.326000000000
Other Non-Current Liabilities 000-20.885-21.846-23.125-2.642-3.758-5.106-6.434-7.745-9.043-10.326-9.1890.7960.8370.8320.850.8680.871049.9320
Total Non-Current Liabilities 44.13846.49650.44859.55956.30377.08812.88518.44131.22442.40849.29354.90665.75468.21167.17772.95978.55561.53563.24272.258085.6250
Total Liabilities 134.126142.35136.744140.338143.926164.04674.37890.70396.102113.063116.793127.571131.803134.469117.857119.803126.527106.074104.254106.69430.033101.7620
Equity:
Preferred Stock 00000000000000000396.343411.874168.10948.19548.19548.195
Common Stock 0.0760.0760.0670.0640.0490.0490.0490.0480.0470.0470.0470.0450.0450.0450.0450.0440.0390.0390.0390.0260.0110.0040
Retained Earnings -795.12-738.769-680.22-631.264-586.718-545.2-503.244-466.262-441.985-401.252-354.535-308.826-263.425-220.892-183.19-154.355-127.973-103.698-83.784-65.267-72.847-60.4560
Accumulated Other Comprehensive Income/Loss 0.2260.150.344-0.135-0.35-0.655-1.228-1.903-3.247-4.319-3.742-3.085-2.066-0.608-0.0590.030.0490.0870.1380.1390.057-0.002-36.847
Other Total Stockholders Equity 1,275.7351,265.5361,056.6651,002.028755.767746.299738.24728.038719.237709.22700.775578.605571.363563.757558.421552.459398.018393.841391.227171.72.977-48.1880
Total Shareholders Equity 480.917526.993376.856370.693168.748200.493233.817259.921274.052303.696342.545266.739305.917342.302375.217398.178270.133290.269307.62106.583-21.607-57.71411.348
Total Equity 480.917526.993376.856370.693168.748200.493233.817259.921274.052303.696342.545266.739305.917342.302375.217398.178270.133290.269307.62106.583-21.607-57.71411.348
Total Liabilities & Shareholders Equity 615.043669.343513.6511.031312.674364.539308.195350.624370.154416.759459.338394.31437.72476.771493.074517.981396.66396.343411.874213.2778.42644.04811.348